Clinical Trial Detail

NCT ID NCT03091478
Title Pembrolizumab in Patients With Leptomeningeal Disease
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sidney Kimmel Comprehensive Cancer Center
Indications

Advanced Solid Tumor

Therapies

Pembrolizumab

Age Groups: adult senior

No variant requirements are available.